Monica Robinson
Optometrist · Sacramento, CANPI 1083741235
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,212 of the $3,021 with a category attached, or 73.2%. 21 manufacturers reported payments, led by Alcon at 33.8% of the total. Reporting peaked in 2023 at $1,392 and has fallen 78.1% since, to $305 in 2025.
Across 70 payments — averaging $43.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- Alcon Research LLC$420
- Glaukos Corporation$308
- Sun Pharmaceutical Industries Inc.$289
- Dompe US, Inc.$218
- AbbVie$127
- plus $638 from 15 others
Across 21 payments — averaging $1777.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Glaukos Corporation$37K
What the payments were for
- Speaking & faculty fees$261%
- Travel & lodging$78326%
- Food & beverage$2,21273%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 8 | $1,021 |
| Alcon Research LLC | 1 | $420 |
| Glaukos Corporation | 11 | $308 |
| Sun Pharmaceutical Industries Inc. | 6 | $289 |
| Dompe US, Inc. | 5 | $218 |
| AbbVie(2 entities) | 6 | $127 |
| Aerie Pharmaceuticals, Inc. | 6 | $126 |
| Rxsight Inc | 6 | $119 |
| Novartis | 5 | $109 |
| Oyster Point Pharma, Inc. | 4 | $71 |
| Rayner Intraocular Lenses Limited | 2 | $30 |
| Harrow Eye, LLC | 1 | $26 |
| Bausch & Lomb Americas Inc. | 1 | $24 |
| Sight Sciences, Inc. | 1 | $20 |
| Ivantis, Inc | 1 | $20 |
| Kala Pharmaceuticals, Inc. | 1 | $19 |
| Iridex Corporation | 1 | $17 |
| Tarsus Pharmaceuticals, Inc. | 1 | $17 |
| Mallinckrodt Hospital Products Inc. | 1 | $14 |
| Thea Pharma Inc. | 1 | $14 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,021 in reported general payments places this provider in the 85th percentile of 6,778 optometrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 43 | $748 |
| Prednisolone Acetate | 24 | $625 |
| Timolol Maleate | 15 | $242 |
| MoxifloxacinMoxifloxacin Hcl | 13 | $239 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 14 | $238 |
| Ofloxacin | 16 | $231 |
| ErythromycinErythromycin Base | 18 | $194 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Sacramento
- Heidi PhamSacramento$271K
- Heidi MillerSacramento$102K
- Steve YoelinNewport Beach$4.1M
- Matthew GellerSpring Valley$3.5M
- Melissa EricksonDavis$522K
- Omid KhodaiLake Forest$499K
- Jason TuSan Diego$351K
- Scott SchachterPismo Beach$312K
- Alicia LauSan Diego$300K
- Vin DangBakersfield$284K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.